Home›Companies›Biotech & Pharma›inSoma Bio

inSoma Bio, Inc.

Updated Oct 27, 2026·Latest SEC filing Jan 22, 2026·Suggest an edit

About inSoma Bio

inSoma Bio is a private company based in Durham, North Carolina. It has reported $6,885,796 raised in four offerings on Form D since July 2020.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 24, 2025Oct 20, 2025amended Jan 22, 2026$2,689,372of $4.0M target15$179KSimple Agreement for Future EquityRule 506(b)Form D/A ↗1 earlier filing
Apr 17, 2023May 1, 2023amended May 6, 2024$2,720,749of $3.0M target16$170KEquity, Amounts exclude the value of securities that automatically converted in the offering and for which prior securities filings have been made.Rule 506(b)Form D/A ↗2 earlier filings
Aug 20, 2020Sep 3, 2020amended Dec 1, 2020$1,273,675of $1.5M target31$41,086Securities on exerciseRule 506(b)Form D/A ↗5 earlier filings
Jun 24, 2020Jul 9, 2020$202,000fully sold7$28,857Securities on exerciseRule 506(b)Form D ↗
Total, four offerings$6,885,796

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on inSoma Bio's Form D filed Jan 22, 2026.

AC
Ashutosh Chilkoti
Executive officer and director
JB
Juliana Blum
Director
SR
Stefan Roberts
Executive officer and director
HB
JA

Sources

  1. SECinSoma Bio, Inc. Form D, filed Oct 20, 2025
  2. SECinSoma Bio, Inc. Form D/A, filed Jun 29, 2023
  3. SECinSoma Bio, Inc. Form D, filed May 1, 2023
  4. SECinSoma Bio, Inc. Form D/A, filed Nov 9, 2020
  5. SECinSoma Bio, Inc. Form D/A, filed Oct 26, 2020
  6. SECinSoma Bio, Inc. Form D/A, filed Oct 13, 2020
  7. SECinSoma Bio, Inc. Form D/A, filed Sep 17, 2020
  8. SECinSoma Bio, Inc. Form D, filed Sep 3, 2020
  9. SECinSoma Bio, Inc. filing history